Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 4/20 | 0.70 |
| ▸ | GNB1 | P62873 | 4/20 | 0.70 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.58 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | NSD2 | O96028 | 1/20 | 0.46 |
| ▸ | ALPL | P05186 | 1/20 | 0.46 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.46 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.46 |
| ▸ | MMP14 | P50281 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10293755 | 0.85 | GNG2 (0.56) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL2777300 | 0.82 | GNG2 (1.00) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL15424239 | 0.80 | GNG2 (0.70) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL14001247 | 0.80 | GNG2 (0.70) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL29588006 | 0.80 | GNG2 (0.70) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL6125804 | 0.80 | GNG2 (0.70) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL21611728 | 0.79 | GNG2 (0.69) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL14030799 | 0.78 | GNG2 (0.67) | GNG2GNB1PTPN7FTOUSP2 | |
| SCHEMBL840931 | 0.77 | KDM4A (0.44) | GNG2GNB1PTPN7USP2KDM4A | |
| SCHEMBL8948052 | 0.76 | GNG2 (0.65) | GNG2GNB1PTPN7FTOUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| EP-1192450-B1 | HIGH ENERGY PHOTOTHERAPEUTIC AGENTS | PROVECTUS PHARMATECH INC (US) | 2014-12-03 | — | — | EP | claimed |
| EP-1753467-B1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | PROVECTUS PHARMATECH INC (US) | 2013-01-09 | — | — | EP | claimed |
| US-7427389-B2 | Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes | PROVECTUS PHARMATECH, INC. (US) | 2008-09-23 | — | — | US | claimed |
| EP-1753467-A4 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS INC (US) | 2008-09-17 | — | — | EP | claimed |
| EP-1311261-B1 | MEDICAMENTS FOR CHEMOTHERAPEUTIC TREATMENT OF DISEASE | PHOTOGEN INC (US) | 2008-01-23 | — | — | EP | claimed |
| EP-1753467-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | Xantech Pharmaceuticals, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| WO-2006001925-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS, INC. (US) | 2006-01-05 | — | — | WO | claimed |
| US-20050276752-A1 | Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes | XANTECH PHARMACEUTICALS, INC. | 2005-12-15 | — | — | US | claimed |
| EP-1292298-A1 | INTRACORPOREAL MEDICAMENTS FOR HIGH ENERGY PHOTOTHERAPEUTIC TREATMENT OF DISEASE | Photogen, Inc. (US) | 2003-03-19 | — | — | EP | claimed |
| EP-1284727-A1 | INTRACORPOREAL MEDICAMENTS FOR PHOTODYNAMIC TREATMENT OF DISEASE | Photogen, Inc. (US) | 2003-02-26 | — | — | EP | claimed |
| US-20020161035-A1 | Medicaments for chemotherapeutic treatment of disease | PHOTOGEN, INC. | 2002-10-31 | — | — | US | claimed |
| EP-1210078-A1 | IMPROVED TOPICAL MEDICAMENTS AND METHODS FOR PHOTODYNAMIC TREATMENT OF DISEASE | Photogen, Inc. (US) | 2002-06-05 | — | — | EP | claimed |
| WO-2002005812-A1 | MEDICAMENTS FOR CHEMOTHERAPEUTIC TREATMENT OF DISEASE | PHOTOGEN, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| US-20020001567-A1 | Intracorporeal medicaments for high energy phototherapeutic treatment of disease | PHOTOGEN, INC. | 2002-01-03 | — | — | US | claimed |
| WO-2001076595-A1 | INTRACORPOREAL MEDICAMENTS FOR HIGH ENERGY PHOTOTHERAPEUTIC TREATMENT OF DISEASE | PHOTOGEN, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| WO-2001072301-A1 | INTRACORPOREAL MEDICAMENTS FOR PHOTODYNAMIC TREATMENT OF DISEASE | PHOTOGEN, INC. (US) | 2001-10-04 | — | — | WO | claimed |
| US-20010022970-A1 | Intracorporeal medicaments for photodynamic treatment of disease | PHOTOGEN, INC. | 2001-09-20 | — | — | US | claimed |
| WO-2001012181-A1 | IMPROVED TOPICAL MEDICAMENTS AND METHODS FOR PHOTODYNAMIC TREATMENT OF DISEASE | PHOTOGEN, INC. (US) | 2001-02-22 | — | — | WO | claimed |